Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

IPH

Innate Pharma (IPH)

Innate Pharma

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:EU:IPH

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
12/19/2023	7:38AM	MF Dow Jones (Italiano)	Le azioni di Innate Pharma salgono dopo l'esercizio dell'opzione dilicenza da parte di Sanofi	EU:IPH	Innate Pharma
12/19/2023	7:28AM	Dow Jones News	Innate Pharma Shares Rise after Sanofi Exercises Licensing Option	EU:IPH	Innate Pharma
12/19/2023	2:39AM	Dow Jones News	Sanofi exerce une option de licence en oncologie auprès d'Innate Pharma	EU:IPH	Innate Pharma
12/19/2023	2:34AM	Dow Jones News	Sanofi exerce une option de licence en oncologie auprès d'Innate Pharma	EU:IPH	Innate Pharma
10/05/2023	8:14AM	Dow Jones News	Innate Pharma Shares Fall Premarket on FDA Partial Study Hold	EU:IPH	Innate Pharma
06/08/2023	10:53AM	Dow Jones News	Innate Pharma Shares Rise 8% After Cancer Treatment Gets Fast Track Designation	EU:IPH	Innate Pharma
12/19/2022	2:25AM	Dow Jones News	Sanofi et Innate Pharma étendent leur collaboration en oncologie avec les cellules NK	EU:IPH	Innate Pharma
08/01/2022	6:30AM	Dow Jones News	Innate Pharma Shares Slide After Failure of Monalizumab in Head, Neck Cancer	EU:IPH	Innate Pharma
09/23/2021	1:00AM	GlobeNewswire Inc.	Nouveau nombre d'actions et de droits de vote d'Innate Pharma au 1er septembre 2021	EU:IPH	Innate Pharma
09/23/2021	1:00AM	GlobeNewswire Inc.	Number of Shares and Voting Rights of Innate Pharma as of September 1, 2021	EU:IPH	Innate Pharma
09/23/2021	1:00AM	GlobeNewswire Inc.	Number of Shares and Voting Rights of Innate Pharma as of September 1, 2021	EU:IPH	Innate Pharma
09/17/2021	7:45AM	GlobeNewswire Inc.	Monalizumab Data From COAST Trial Presented at ESMO Congress 2021	EU:IPH	Innate Pharma
09/17/2021	7:45AM	GlobeNewswire Inc.	Présentation de Données Issues de l'Essai COAST Comprenant Monalizumab au Congrès de l'ESMO 2021	EU:IPH	Innate Pharma
09/17/2021	7:45AM	GlobeNewswire Inc.	Monalizumab Data from COAST Trial Presented at ESMO Congress 2021	EU:IPH	Innate Pharma
09/15/2021	1:00AM	GlobeNewswire Inc.	Innate Pharma reports first half 2021 financial results and business update	EU:IPH	Innate Pharma
09/15/2021	1:00AM	GlobeNewswire Inc.	Innate Pharma présente ses résultats financiers et l'avancée de son portefeuille au premier semestre 2021	EU:IPH	Innate Pharma
09/15/2021	1:00AM	GlobeNewswire Inc.	Rapport Financier Semestriel 30 juin 2021	EU:IPH	Innate Pharma
09/15/2021	1:00AM	GlobeNewswire Inc.	Innate Pharma Reports First Half 2021 Financial Results and Business Update	EU:IPH	Innate Pharma
09/07/2021	1:00AM	GlobeNewswire Inc.	Innate Pharma Organise une Conférence Téléphonique et un Webcast pour ses Résultats Financiers au Premier Semestre 2021	EU:IPH	Innate Pharma
09/07/2021	1:00AM	GlobeNewswire Inc.	Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business Update	EU:IPH	Innate Pharma
09/07/2021	1:00AM	GlobeNewswire Inc.	Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business Update	EU:IPH	Innate Pharma
09/02/2021	2:00AM	GlobeNewswire Inc.	Monalizumab and ANKET™ Data Will Be Presented at ESMO 2021 Virtual Congress	EU:IPH	Innate Pharma
09/02/2021	2:00AM	GlobeNewswire Inc.	Des données sur monalizumab et ANKET™ seront présentées au congrès virtuel de l’ESMO 2021	EU:IPH	Innate Pharma
09/02/2021	2:00AM	GlobeNewswire Inc.	Monalizumab and ANKET™ Data Will be Presented at ESMO 2021 Virtual Congress	EU:IPH	Innate Pharma
08/30/2021	1:00AM	GlobeNewswire Inc.	Innate Pharma to Participate in Upcoming Investor Conferences	EU:IPH	Innate Pharma
08/30/2021	1:00AM	GlobeNewswire Inc.	Innate Pharma to Participate in Upcoming Investor Conferences	EU:IPH	Innate Pharma
08/30/2021	1:00AM	GlobeNewswire Inc.	Prochains Rendez-Vous Investisseurs d'Innate Pharma	EU:IPH	Innate Pharma
08/11/2021	1:00AM	GlobeNewswire Inc.	Number of Shares and Voting Rights of Innate Pharma as of August 1, 2021	EU:IPH	Innate Pharma
08/11/2021	1:00AM	GlobeNewswire Inc.	Nouveau Nombre d'Actions et de Droits de Vote d'Innate Pharma au 1er Aout 2021	EU:IPH	Innate Pharma
08/11/2021	1:00AM	GlobeNewswire Inc.	Number of Shares and Voting Rights of Innate Pharma as of August 1, 2021	EU:IPH	Innate Pharma

Showing the most relevant articles for your search:EU:IPH

1 2 3 4 5 6 7 8 9 10 Next >>

Cassava Sciences

Enzolytics (PK)

Moon Equity (PK)

Enanta Pharmaceuticals

Anavex Life Sciences

Brookmount Explorations (PK)

Digital Brand Media and ... (PK)

Global Developments (PK)

AMC Entertainment

ERHC Energy (CE)

Good Vibrations Shoes (PK)

Kraig Biocraft Laborator... (QB)

Lightwave Logic

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions